Knowledge Hub

Prostate Cancer Therapeutics Report According To Industry Analysis, Market Size, Share, Growth, Trends, Forecast 2016 - 2024

Press release   •   Apr 18, 2017 04:43 EDT

About Prostate Cancer Therapeutics Market

Global Prostate Cancer Therapeutics Market: Overview

This report on the prostate cancer therapeutics market analyzes the current and future scenario of the global market. Increasing prevalence of prostate cancer, launch of promising emerging therapies, as well as innovation in the development of new drugs & therapeutic biological products, and high growth in hormone-refractory prostate cancer drug due to lesser side effects are some of the drivers expected to drive the global prostate cancer therapeutics market during the forecast period.

The global prostate cancer therapeutics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country’s market with respect to the segments based on therapy type, distribution channels and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global prostate cancer therapeutics market.

Global Prostate Cancer Therapeutics Market: Key Segments

Based on therapy type, the market has been segmented into hormone therapy, chemotherapy, biologic therapy and targeted therapy. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference from oncologists for treating the prostate cancer with various drug classes. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Get Sample Copy of this report @ http://www.marketresearchreports.biz/sample/sample/1064481

Based on distribution channels, the global prostate cancer therapeutics market has been segmented into hospital pharmacy, retail pharmacy, online sales and others. The market segments have been extensively analyzed based on increase in demand for disease treatment among prostate cancer patients. Increased patient hospitalization for the treatment of prostate cancer are driving the market share of hospital pharmacy segment. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Prostate Cancer Therapeutics Market: Regional Outlook

Geographically, the global prostate cancer therapeutics market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

View Report @ http://www.marketresearchreports.biz/analysis/1064481

Companies Mentioned in Report

The report also profiles major players in the global prostate cancer therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include players in the global prostate cancer therapeutics market are Amgen, Inc., Johnson & Johnson (Janssen Biotech, Inc.), Pfizer, Inc., AstraZeneca, AbbVie, Inc., Bayer AG, Ipsen Group, Sanofi, Endo Pharmaceuticals, Inc., Dendreon Corporation (Sanpower Group Co. Ltd.) and others.

The Global Prostate Cancer Therapeutics Market is segmented as given below:

Global Prostate Cancer Therapeutics Market, by Therapy

Hormone Therapy

Luteinizing Hormone-Releasing Hormone Analogs

Luteinizing Hormone-Releasing Hormone Antagonists

Antiandrogens

Chemotherapy

Systemic Chemotherapy

Regional Chemotherapy

Biologic Therapy

Targeted Therapy

Global Prostate Cancer Therapeutics Market, by Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Sales

Others

Global Prostate Cancer Therapeutics Market, by Geography

North America

U.S.

Canada

Europe

Germany

U.K.

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

Japan

India

China

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

Saudi Arabia

South Africa

UAE

Rest of Middle East & Africa

Table of Content

Chapter 1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology

2.1. Assumptions

2.2. Research Methodology

Chapter 3. Executive Summary

3.1. Global Prostate Cancer Therapeutics Market : Snapshot, 2015

3.2. Global Prostate Cancer Therapeutics Market : Opportunity Map

Chapter 4. Market Overview

4.1. Product Overview

4.2. Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2014–2024

4.3. Global Prostate Cancer Therapeutics Market Outlook

4.4. Global Prostate Cancer Therapeutics Market : Key Industry Events

4.5. Global Prostate Cancer Therapeutics Market : Porter's Analysis

4.6. Global Prostate Cancer Therapeutics Market : Pipeline Analysis

4.7. Key Product Opportunities

Chapter 5. Market Dynamics

5.1. Drivers and Restraints Snapshot Analysis

5.2. Drivers

5.2.1. Increasing prevalence of prostate cancer

5.2.2. Launch of promising emerging therapies

5.2.3. Innovation in the development of new drugs and therapeutic biological products

5.2.4. High growth in hormone-refractory prostate cancer drug due to lesser side effects

5.3. Restrains

5.3.1. High cost of treatment

5.3.2. Reluctance toward adoption of premium treatments

5.4. Opportunity Analysis

5.5. Opportunities

5.5.1. Large undiagnosed patient population

5.5.2. Rise in funding from both public and private sector in the field of drug development

5.6. Key Trends

5.6.1. Increasing application of biotechnology in anticancer drugs development

5.6.2. New drugs entering the market with higher costs

5.6.3. Oral drugs account for a large share of the oncology drugs market

Chapter 6. Prostate Cancer Therapeutics Market Analysis, by Product Type

6.1. Prostate Cancer Therapeutics Market Analysis, by Therapy

6.2. Key Findings

6.3. Introduction

6.4. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Therapy

6.5. Prostate Cancer Therapeutics Market Analysis, by Therapy

6.5.1. Hormone Therapy

6.5.2. Luteinizing Hormone-Releasing Hormone Analogs

6.5.3. Luteinizing Hormone-Releasing Hormone Antagonists

6.5.4. Antiandrogens

6.6. Chemotherapy

6.6.1. Systemic Chemotherapy

6.6.2. Regional Chemotherapy

6.7. Biologic Therapy

6.8. Targeted Therapy

6.9. Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024

6.10. Key Trends

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.